1. Therapeutic efficacy of the somatostatin analog SMS;Ho, K.Y.; Weissberger, A.J.; Marbach, P.; Lazarus, L.;Ann Intern Med; in acromegaly,1990
2. Gallstones during octreotide therapy;Dowling, R.H.; Hussaini, S.H.; Murphy, G.M.; Besser, G.M.; Wass, J.A.H.;Metabolism,1992
3. Gallstone recurrence and post-dissolution management;Dowling, R.H.; Gleeson, D.; Ruppin, D.C.; Murphy, G.M.,1984
4. Post prandial gallbladder motility during long term treatment with the long-acting somatostatin analogue SMS 201-955 in acromegaly;van Liessum PA; WP, Hopman; GF, Pieters; JB, Jansen; AG, Smals; G, Rosenbusch;Jf Clin Endocrinol Metab,1989
5. The effect of octreotide on gallstone prevalence and gallbladder motility in acromegaly;Catnach, S.M.; Anderson, J.V.; Fairclough, P.D.; Trembath, R.C.; Wilson, P.A.J.; Parker, E.;Gut,1993